Literature DB >> 10204439

Percutaneous laser disc decompression (PLDD): twelve years' experience with 752 procedures in 518 patients.

D S Choy1.   

Abstract

BACKGROUND AND
OBJECTIVE: Percutaneous laser disc decompression (PLDD) is a procedure in which herniated intervertebral discs are treated by reduction of intradiscal pressure through laser energy. This is introduced by a needle inserted into the nucleus pulposus under local anesthesia and fluoroscopic monitoring. The small volume of nucleus vaporized results in a sharp fall of intradiscal pressure, with consequent migration of the herniation away from the nerve root. First proposed by the author in 1984, this concept was validated by 2 years of in vitro experiments. Our aim was to apply this concept to a large series of patients with herniated disc disease. STUDY DESIGN/
MATERIALS AND METHODS: A nonrandomized, nonblinded study was conducted in male and female patients with symptomatic, image-documented intervertebral herniated discs in a 12-year period using PLDD as the only treatment modality.
RESULTS: The author's own series consists of 752 intervertebral discs in 518 patients over a period of 12 years. The overall success rate ranged from 75% to 89% with a complication rate of less than 1%.
CONCLUSION: PLDD has proven to be safe and effective. It is minimally invasive, is performed in an outpatient setting, requires no general anesthesia, results in no scarring or spinal instability, reduces rehabilitation time, is repeatable, and does not preclude open surgery should that become necessary.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10204439     DOI: 10.1089/clm.1998.16.325

Source DB:  PubMed          Journal:  J Clin Laser Med Surg        ISSN: 1044-5471


  19 in total

Review 1.  Cavitation in medicine.

Authors:  Christopher Earls Brennen
Journal:  Interface Focus       Date:  2015-10-06       Impact factor: 3.906

Review 2.  Percutaneous laser disk decompression: a review of the literature.

Authors:  B Schenk; P A Brouwer; W C Peul; M A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

3.  Mid-term efficacy of percutaneous laser disc decompression for treatment of cervical vertigo.

Authors:  Longxi Ren; Baofeng Guo; Jianhua Zhang; Zhengfeng Han; Tongtong Zhang; Qiutie Bai; Yanjun Zeng
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-07-03

4.  Efficacy of percutaneous laser disc decompression on lumbar spinal stenosis.

Authors:  Longxi Ren; Zhengfeng Han; Jianhua Zhang; Tongtong Zhang; Jian Yin; Xibin Liang; Han Guo; Yanjun Zeng
Journal:  Lasers Med Sci       Date:  2013-08-31       Impact factor: 3.161

5.  Outcome of patients with lumbar spinal canal stenosis due to discogenic under percutaneous laser disc decompression.

Authors:  Ahmad Shekarchizadeh; Ali Mohammadi-Moghadam; Majid Rezvani; Peyman Rahmani; Nourallah Eshraghi; Keyvan Ghadimi
Journal:  Am J Neurodegener Dis       Date:  2020-12-15

6.  Percutaneous laser disc decompression for thoracic disc disease: report of 10 cases.

Authors:  Scott M W Haufe; Anthony R Mork; Morgan Pyne; Ryan A Baker
Journal:  Int J Med Sci       Date:  2010-06-01       Impact factor: 3.738

7.  Factors predicting excellent outcome of percutaneous cervical discectomy: analysis of 111 consecutive cases.

Authors:  Y Ahn; S H Lee; S C Lee; S W Shin; S E Chung
Journal:  Neuroradiology       Date:  2004-04-22       Impact factor: 2.804

8.  Automated percutaneous lumbar discectomy: technique, indications and clinical follow-up in over 1000 patients.

Authors:  G Bonaldi
Journal:  Neuroradiology       Date:  2003-09-13       Impact factor: 2.804

9.  The Comparison of the Result of Epiduroscopic Laser Neural Decompression between FBSS or Not.

Authors:  Dae Hyun Jo; Eung Don Kim; Hyun Jin Oh
Journal:  Korean J Pain       Date:  2013-12-31

10.  Treatment of cervical disc herniation through percutaneous minimally invasive techniques.

Authors:  Bo Yang; Jingkai Xie; Biao Yin; Le Wang; Shibing Fang; Shengyu Wan
Journal:  Eur Spine J       Date:  2013-10-19       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.